New and Notable Evidence 2022
View this email in your browser
Trusted evidence. Informed decisions. Better health.

New and Notable Evidence | September 2022

Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!



Cervical Dilators Used Concurrently With Misoprostol to Shorten Labor in Second-Trimester Termination of Pregnancy: A Randomized Controlled Trial.
Anselem O, Jouannic JM, Winer N, Bouchghoul H, Vivanti AJ, Quibel T, Massardier J, Rousseau J, Ancel PY, Goffinet F, Tsatsaris V.
Obstet Gynecol. 2022 Aug 3. 
DOI: 10.1097/AOG.0000000000004887. PMID: 35926202

Comparison of the Effects of Hysteroscopic Cold Broad Sword Play Combined with Estrogen and Progestin Sequential Therapy and Drospirenone and Ethinylestradiol Tablets in Patients with Severe Intrauterine Adhesion. [FREE FULL TEXT]
Zhou L, Zhou L, Wang T.
Emerg Med Int. 2022 Jul 31;2022:9898228. 
DOI: 10.1155/2022/9898228. PMID: 35959221 

Effect of Propofol Intravenous Anesthesia Combined with Press-Needle Therapy on Analgesic Effect during Painless Abortion. [FREE FULL TEXT]
Zhu X, He X, Fan B, Liu J, Wu S, Wang H, Chen C.
Comput Math Methods Med. 2022 Aug 8;2022:6543211. 
DOI: 10.1155/2022/6543211. PMID: 35979057 

Ketamine Compared With Fentanyl for Surgical Abortion: A Randomized Controlled Trial.
Chin J, McGrath M, Lokken E, Upegui CD, Prager S, Micks E.
Obstet Gynecol. 2022 Aug 3. 
DOI: 10.1097/AOG.0000000000004903. PMID: 35926204

Association between previous abortion history and risk of autism spectrum disorders among offspring: A meta-analysis. [FREE FULL TEXT]
Jenabi E, Ayubi E, Bashirian S, Seyedi M, Rezaei M.
Clin Exp Pediatr. 2022 Aug 17. 
DOI: 10.3345/cep.2022.00108. PMID: 35996797 

Economic evaluation of medical versus surgical strategies for first trimester therapeutic abortion: A systematic review. [FREE FULL TEXT]
Barghazan SH, Hadian M, Rezapour A, Nassiri S.
J Educ Health Promot. 2022 Jun 30;11:184. 
DOI: 10.4103/jehp.jehp_1274_21. PMID: 36003248 

Healthcare professionals and students' knowledge on termination of pregnancy legislation and clinical practice: A systematic review. [FREE FULL TEXT]
Leitao S, O'Shaughnessy E, San Lazaro Campillo I, O'Donoghue K.
Sex Reprod Healthc. 2022 Aug 6;33:100762. 
DOI: 10.1016/j.srhc.2022.100762. PMID: 35963202 

Impacts of COVID-19 on contraceptive and abortion services in low- and middle-income countries: a scoping review. [FREE FULL TEXT]
Polis CB, Biddlecom A, Singh S, Ushie BA, Rosman L, Saad A.
Sex Reprod Health Matters. 2022 Dec;30(1):2098557. 
DOI: 10.1080/26410397.2022.2098557. PMID: 35920612 

Motherwort Injection for Preventing Uterine Hemorrhage in Women With Induced Abortion: A Systematic Review and Meta-Analysis of Randomized Evidence. [FREE FULL TEXT]
Xinyu X, Xintong T, Youping L, Feng W, Jiajie Y.
Front Pharmacol. 2022 Jul 21;13:916665. 
DOI: 10.3389/fphar.2022.916665. PMID: 35935833 


The effect of sex, menstrual cycle phase and oral contraceptive use on intestinal permeability and ex-vivo monocyte TNFα release following treatment with lipopolysaccharide and hyperthermia. [FREE FULL TEXT]
Flood TR, Kuennen MR, Blacker SD, Myers SD, Walker EF, Lee BJ.
Cytokine. 2022 Aug 6;158:155991. 
DOI: 10.1016/j.cyto.2022.155991. PMID: 35944412

Initiating Intramuscular Depot Medroxyprogesterone Acetate (DMPA-IM) Increases Frequencies of Th17-like Human Immunodeficiency Virus (HIV) Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Bunjun R, Ramla TF, Jaumdally SZ, Noël-Romas L, Ayele H, Brown BP, Gamieldien H, Harryparsad R, Dabee S, Nair G, Onono M, Palanee-Phillips T, Scoville CW, Heller KB, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Jaspan H, Heffron R.
Clin Infect Dis. 2022 Aug 9:ciac284. 
DOI: 10.1093/cid/ciac284. PMID: 35941737

Lactogenesis and breastfeeding after immediate versus delayed birth-hospitalization insertion of etonogestrel contraceptive implant: A non-inferiority trial.
Henkel A, Lerma K, Reyes G, Gutow H, Shaw JG, Shaw KA.
Am J Obstet Gynecol. 2022 Aug 11:S0002-9378(22)00644-5. 
DOI: 10.1016/j.ajog.2022.08.012. PMID: 35964661

Placement of an intrauterine device within 48 hours after early medical abortion - a randomized controlled trial. [FREE FULL TEXT}
Hogmark S, Lichtenstein Liljeblad K, Envall N, Gemzell-Danielsson K, Kopp Kallner H.
Am J Obstet Gynecol. 2022 Aug 12:S0002-9378(22)00646-9. 
DOI: 10.1016/j.ajog.2022.07.063. PMID: 35970199 

Removal of a well-palpable one-rod subdermal contraceptive implant using a dedicated hand-held device or standard technique: a randomized, open-label, non-inferiority trial.
Hubacher D, Byamugisha J, Kakaire O, Nalubwama H, Emtell Iwarsson K, Bratlie M, Chen PL, Gemzell-Danielsson K.
Hum Reprod. 2022 Aug 12:deac179. 
DOI: 10.1093/humrep/deac179. PMID: 35960174

Adolescents' Contraceptive Uptake in Ethiopia: A Meta-Analysis. {FREE FULL TEXT]
Mekonnen AG, Odo DB, Nigatu D.
Biomed Res Int. 2022 Aug 16;2022:6104467. 
DOI: 10.1155/2022/6104467. PMID: 36017384 

Effects of orally administered hormonal contraceptives on the musculoskeletal system of healthy premenopausal women-A systematic review. [FREE FULL TEXT]
Römer C, Czupajllo J, Wolfarth B, Lerchbaumer MH, Legerlotz K.
Health Sci Rep. 2022 Aug 10;5(5):e776. 
DOI: 10.1002/hsr2.776. PMID: 35957969

Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
Christelle K, Norhayati MN, Jaafar SH.
Cochrane Database Syst Rev. 2022 Aug 26;8(8):CD006034. 
DOI: 10.1002/14651858.CD006034.pub3. PMID: 36017945 

Low condom use at the last sexual intercourse among university students in sub-Saharan Africa: Evidence from a systematic review and meta-analysis. [FREE FULL TEXT]
Izudi J, Okello G, Semakula D, Bajunirwe F.
PLoS One. 2022 Aug 10;17(8):e0272692. 
DOI: 10.1371/journal.pone.0272692. PMID: 35947583 

Oral Contraceptive and Glioma Risk: A Prospective Cohort Study and Meta-Analysis. [FREE FULL TEXT]
Shao C, Tang H, Wang X, He J, Wang P, Wu N.
Front Public Health. 2022 Jul 14;10:878233. 
DOI: 10.3389/fpubh.2022.878233. PMID: 35910887 

Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women. [FREE FULL TEXT]
Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Jensen JT, Westhoff CL, Jost M, Foidart JM, Creinin MD.
Contraception. 2022 Aug 1:S0010-7824(22)00218-9. 
DOI: 10.1016/j.contraception.2022.07.010. PMID: 35921872 

Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials. [FREE FULL TEXT]
Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Apter D, Jost M, Foidart JM, Creinin MD.
Contraception. 2022 Jul 31:S0010-7824(22)00215-3. 
DOI: 10.1016/j.contraception.2022.07.009. PMID: 35921870

Pregnancy History, Oral Contraceptive Pills Consumption (OCPs), and Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis. [FREE FULL TEXT]
Ghajarzadeh M, Mohammadi A, Shahraki Z, Sahraian MA, Mohammadifar M.
Int J Prev Med. 2022 Jun 24;13:89. 
DOI: 10.4103/ijpvm.IJPVM_299_20. PMID: 35958357 

Family Planning 

Effectiveness of targeted antenatal family planning information provision on early postpartum family planning uptake in Kisumu County: Protocol for a simple randomized control trial (I DECIDE Study). [FREE FULL TEXT]
Shisanya MS, Ouma C, Kipmerewo M.
PLoS One. 2022 Aug 15;17(8):e0264807. 
DOI: 10.1371/journal.pone.0264807. PMID: 35969536 

Interventions for and experiences of shared decision-making underpinning reproductive health, family planning options and pregnancy for women with or at high risk of kidney disease: a systematic review and qualitative framework synthesis. [FREE FULL TEXT]
Mc Laughlin L, Neukirchinger B, Noyes J.
BMJ Open. 2022 Aug 8;12(8):e062392. 
DOI: 10.1136/bmjopen-2022-062392. PMID: 35940837 

Who Benefits from School-Based Teen Pregnancy Prevention Programs? Examining Multidimensional Moderators of Program Effectiveness Across Four Studies.
Vasilenko SA, Odejimi OA, Glassman JR, Potter SC, Drake PM, Coyle KK, Markham C, Emery ST, Peskin MF, Shegog R, Addy RC, Clark LF.
Prev Sci. 2022 Aug 22. 
DOI: 10.1007/s11121-022-01423-y. PMID: 35994193
Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!

New & Notable Evidence is a free monthly email service of the
Cochrane Fertility Regulation Review Group

Keep up to date and subscribe here!
Copyright © 2022 Cochrane Fertility Regulation Group, All rights reserved.

unsubscribe from this list    update subscription preferences 

Please note: unsubscribing will remove you from the Cochrane Fertility Regulation Group's mailing list, but it will not automatically unsubscribe you from other Cochrane Groups' mailing lists or from Cochrane’s organizational mailing lists which you can manage at

Email Marketing Powered by Mailchimp